NASDAQ: CRMD

CorMedix Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8, 2020 and May 13, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 20, 2021.

If you purchased CorMedix securities between July 8, 2020 and May 13, 2021 and would like to join the action, please click “Join This Class Action.”

集体诉讼期:July 8, 2020 through May 13, 2021
If you purchased CorMedix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

案件详情:

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

  • deficiencies existed with respect to the manufacturing process of DefenCath, a purported novel antibacterial and antifungal solution designed to prevent costly and dangerous catheter-related bloodstream infections (“CRBSIs”), and/or at the facility responsible for manufacturing DefenCath;
  • in light of the foregoing deficiencies, the U.S. Food and Drug Administration (“FDA”) was unlikely to approve the DefenCath New Drug Application (“NDA”) for CRBSIs in its present form;
  • defendants had downplayed the true scope of the deficiencies regarding DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; and
  • as a result, the Company’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

关注我们:
公司名称: CorMedix Inc.
股票代号: CRMD
集体诉讼期: July 8, 2020 through May 13, 2021
法院: United States District Court for the District of New Jersey

为何选择罗森律师事务所?

自 2013 年以来,罗森律师事务所每年都是代表投资者成功提起证券集体诉讼的前四大律所之一。仅 2019 年,本律所就为投资者追回 4.38 亿美元资金。

投资者应仔细鉴别和遴选在引领证券集体诉讼方面有多年成功经验的的律师。通常,其他律所会发布关于集体诉讼的新闻稿,但却没有类似的经验或资源。

机构股东服务公司按 2017 年证券集体诉讼索赔数量,罗森律师事务所列为第一名。

罗森律师事务所为全球投资者提供代理服务。我们的使命是提起证券欺诈集体诉讼以及保护股东的权利。

Scroll to Top